Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trialNadel, Simon, FRCP ; Goldstein, Brahm, MD ; Williams, Mark D, MD ; Dalton, Heidi, MD ; Peters, Mark, PhD ; Macias, William L, MD ; Abd-Allah, Shamel A, MD ; Levy, Howard, FRCP ; Angle, Robinette, RN ; Wang, Dazhe, PhD ; Sundin, David P, PhD ; Giroir, Brett, DrThe Lancet (British edition), 2007-03, Vol.369 (9564), p.836-843 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatmentVincent, Jean-Louis ; Bernard, Gordon R ; Beale, Richard ; Doig, Christopher ; Putensen, Christian ; Dhainaut, Jean-Francois ; Artigas, Antonio ; Fumagalli, Roberto ; Macias, William ; Wright, Theressa ; Wong, Kar ; Sundin, David P ; Turlo, Mary Ann ; Janes, JonathanCritical care medicine, 2005-10, Vol.33 (10), p.2266-2277 [Periódico revisado por pares]Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & WilkinsTexto completo disponível |
|
3 |
Material Type: Artigo
|
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertensionBarst, Robyn J., MD ; Oudiz, Ronald J., MD ; Beardsworth, Anthony, MD ; Brundage, Bruce H ; Simonneau, Gerald, MD ; Ghofrani, Hossein A., MD ; Sundin, David P., PhD ; Galiè, Nazzareno, MDThe Journal of heart and lung transplantation, 2011-06, Vol.30 (6), p.632-643 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled TrialPorst, Hartmut ; Kim, Edward D ; Casabé, Adolfo R ; Mirone, Vincenzo ; Secrest, Roberta J ; Xu, Lei ; Sundin, David P ; Viktrup, LarsEuropean urology, 2011-11, Vol.60 (5), p.1105-1113 [Periódico revisado por pares]Kidlington: Elsevier B.VTexto completo disponível |
|
5 |
Material Type: Artigo
|
Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndromeNORDEN, Anthony G. W ; LAPSLEY, Marta ; UNWIN, Robert J ; VERROUST, Pierre ; MOESTRUP, Søren K ; IGARASHI, Takashi ; KELLEHER, Catherine L ; LEE, Philip J ; MATSUYAMA, Takeshi ; SCHEINMAN, Steven J ; SHIRAGA, Hiroshi ; SUNDIN, David P ; THAKKER, Rajesh VJournal of the American Society of Nephrology, 2002, Vol.13 (1), p.125-133 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
|
6 |
Material Type: Artigo
|
Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsisVincent, Jean-Louis ; O'Brien, Jr, James ; Wheeler, Arthur ; Wittebole, Xavier ; Garg, Rekha ; Trzaskoma, Benjamin L ; Sundin, David PCritical care (London, England), 2006-01, Vol.10 (3), p.R74-R74, Article R74 [Periódico revisado por pares]England: National Library of Medicine - MEDLINE AbstractsTexto completo disponível |
|
7 |
Material Type: Artigo
|
Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)Levi, Marcel ; Levy, Mitchell ; Williams, Mark D ; Douglas, Ivor ; Artigas, Antonio ; Antonelli, Massimo ; Wyncoll, Duncan ; Janes, Jonathan ; Booth, Frank V ; Wang, Dazhe ; Sundin, David P ; Macias, William L ; Xigris and Prophylactic HepaRin Evaluation in Severe Sepsis (XPRESS) Study GroupAmerican journal of respiratory and critical care medicine, 2007-09, Vol.176 (5), p.483-490 [Periódico revisado por pares]New York, NY: Am Thoracic SocTexto completo disponível |
|
8 |
Material Type: Artigo
|
Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicityGirton, Richard A ; Sundin, David P ; Rosenberg, Mark EAmerican journal of physiology. Renal physiology, 2002-04, Vol.282 (4), p.703-F709 [Periódico revisado por pares]United StatesTexto completo disponível |
|
9 |
Material Type: Artigo
|
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomesMartin, Greg ; Brunkhorst, Frank M ; Janes, Jonathan M ; Reinhart, Konrad ; Sundin, David P ; Garnett, Kassandra ; Beale, RichardCritical care (London, England), 2009-01, Vol.13 (3), p.R103-R103 [Periódico revisado por pares]England: National Library of Medicine - MEDLINE AbstractsTexto completo disponível |
|
10 |
Material Type: Artigo
|
Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated databasePayen, Didier, MD, PhD ; Sundin, David P., PhD ; Nelson, David R., MS ; Williams, Mark D., MDSurgery, 2007-09, Vol.142 (3), p.426-427 [Periódico revisado por pares]United States: Mosby, IncTexto completo disponível |